MEDU-36. MERIVA® AND A NOVEL CHEMICALLY-MODIFIED CURCUMIN FOR THE TREATMENT OF MEDULLOBLASTOMA

Medulloblastoma is the most common pediatric central nervous system cancer, and despite an overall favorable prognosis with intensive multimodal treatment, children are especially at risk for significant negative effects of these treatments. There is a need for treatments that are less toxic with fe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Wright, Avery, Stuart, Benjamin, Ruggieri, Rosamaria, Chakraborty, Shamik, Kelley, Kevin, Wechsler-Reya, Robert, Johnson, Francis, Golub, Lorne, Scaduto, Joseph, Symons, Marc
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475164/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.186
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia